Check MEDSynth spin-offs
beenext is a Spin Off at the University of Turin born inside the UniTO's Department of Science and Drug Technology (DSTF).
beenext was funded in the 2013 by three DSTF members with the purpose to move to the market both the Department research discoveries and the educational knowledge present in department.
beenext is active in major fields:
Innovative scientific glassware
Watch the video!
For order and information, just send an email at firstname.lastname@example.org or at email@example.com
DDC aims the pharmaceutical development of Dihydroorotate Dehydrogenase inhibitors and has the goal of bringing its best molecule to the clinical stage within 1 or 2 years. It is a potential new drug for the treatment of Acute Myeloid Leukemia (AML) that could significantly improve patient’s survival over 5 years.
Our multidisciplinary team, led by professionals with a long track record in drug development and clinic, relies on highly skilled personnel with unique competence in developing integrated solutions.